Richard Armer

654 total citations
27 papers, 493 citations indexed

About

Richard Armer is a scholar working on Organic Chemistry, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Richard Armer has authored 27 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Animal Science and Zoology. Recurrent topics in Richard Armer's work include Synthesis and Biological Evaluation (6 papers), Coccidia and coccidiosis research (5 papers) and Urticaria and Related Conditions (3 papers). Richard Armer is often cited by papers focused on Synthesis and Biological Evaluation (6 papers), Coccidia and coccidiosis research (5 papers) and Urticaria and Related Conditions (3 papers). Richard Armer collaborates with scholars based in United Kingdom, Hungary and India. Richard Armer's co-authors include Roy Pettipher, Trevor T. Hansel, Luzheng Xue, Lucien Gazi, Michael Hunter, Mark A. Payton, Graham Speight, Elizabeth Townsend, Simon A. Woodcock and Matilda Bingham and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Reviews Drug Discovery.

In The Last Decade

Richard Armer

25 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Armer United Kingdom 9 171 161 101 94 67 27 493
Masayuki Nakazawa Japan 13 106 0.6× 132 0.8× 46 0.5× 73 0.8× 51 0.8× 25 438
Helen Galczenski United States 9 187 1.1× 171 1.1× 113 1.1× 41 0.4× 59 0.9× 9 438
E.D. Salter United States 10 160 0.9× 140 0.9× 147 1.5× 84 0.9× 17 0.3× 12 430
Hana Yamane Japan 8 165 1.0× 123 0.8× 172 1.7× 237 2.5× 32 0.5× 9 494
Ermengilda McCauley United States 9 92 0.5× 117 0.7× 104 1.0× 123 1.3× 28 0.4× 11 382
Dawn A. Bradbury United Kingdom 8 93 0.5× 149 0.9× 78 0.8× 120 1.3× 44 0.7× 9 396
Britta Lundquist Sweden 10 89 0.5× 220 1.4× 80 0.8× 48 0.5× 26 0.4× 20 357
Håkan Bergstrand Sweden 13 192 1.1× 314 2.0× 191 1.9× 35 0.4× 156 2.3× 40 655
John A. Mitchell United States 10 119 0.7× 404 2.5× 119 1.2× 26 0.3× 37 0.6× 18 777
Susumu Tsujimoto Japan 14 95 0.6× 261 1.6× 70 0.7× 36 0.4× 19 0.3× 36 502

Countries citing papers authored by Richard Armer

Since Specialization
Citations

This map shows the geographic impact of Richard Armer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Armer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Armer more than expected).

Fields of papers citing papers by Richard Armer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Armer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Armer. The network helps show where Richard Armer may publish in the future.

Co-authorship network of co-authors of Richard Armer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Armer. A scholar is included among the top collaborators of Richard Armer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Armer. Richard Armer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flanagan, Eimear, Richard Armer, Clifford D. Jones, et al.. (2022). The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand–dependent Cancer Models. Cancer Research Communications. 2(9). 914–928. 19 indexed citations
2.
Woodcock, Simon A., et al.. (2022). Abstract 2566: Pre-clinical efficacy of the Wnt pathway inhibitor RXC004 in combination with anti-cancer therapies. Cancer Research. 82(12_Supplement). 2566–2566. 2 indexed citations
3.
Armer, Richard, et al.. (2018). Abstract 3764: Porcupine inhibitor RXC004 enhances immune response in pre-clinical models of cancer. Cancer Research. 78(13_Supplement). 3764–3764. 9 indexed citations
6.
Pettipher, Roy, Luzheng Xue, Graham Speight, et al.. (2011). Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils. Journal of Pharmacology and Experimental Therapeutics. 340(2). 473–482. 59 indexed citations
7.
Pettipher, Roy, Trevor T. Hansel, & Richard Armer. (2007). Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nature Reviews Drug Discovery. 6(4). 313–325. 246 indexed citations
8.
Armer, Richard, et al.. (2006). Recent disclosures of clinical drug candidates.. PubMed. 19(1). 183–72. 1 indexed citations
9.
Armer, Richard, Mark Ashton, Frederick A. Brookfield, et al.. (2005). Indole-3-acetic Acid Antagonists of the Prostaglandin D2 Receptor CRTH2. Journal of Medicinal Chemistry. 48(20). 6174–6177. 39 indexed citations
10.
Armer, Richard, et al.. (2004). Non-Peptidic GnRH Receptor Antagonists. Current Medicinal Chemistry. 11(22). 3017–3028. 27 indexed citations
11.
Armer, Richard. (2000). Inhibitors of Mammalian Central Nervous System Selective Amino Acid Transporters. Current Medicinal Chemistry. 7(2). 199–209. 10 indexed citations
12.
Armer, Richard, et al.. (2000). Recent advances in atypical antipsychotics.. PubMed. 3(8). 920–34. 1 indexed citations
13.
Armer, Richard, et al.. (1999). 8-aminoquinolines as anticoccidials - part III. Bioorganic & Medicinal Chemistry Letters. 9(16). 2425–2430. 6 indexed citations
14.
Armer, Richard, et al.. (1998). ANTICOCCIDIAL ACTIVITY OF NOVEL SEMI-SYNTHETIC ANALOGUES OF FRENOLICIN B(I). Heterocyclic Communications. 4(4). 309–316. 4 indexed citations
15.
Armer, Richard, et al.. (1998). Carbocyclic Frenolicin analogues: Novel anticoccidial agents. Bioorganic & Medicinal Chemistry Letters. 8(2). 139–142. 12 indexed citations
16.
Armer, Richard, et al.. (1998). 8-Aminoquinolines as anticoccidials — II. Bioorganic & Medicinal Chemistry Letters. 8(12). 1487–1492. 4 indexed citations
17.
Armer, Richard, et al.. (1998). ANTICOCCIDIAL ACTIVITY OF NOVEL SEMI-SYNTHETIC ANALOGUES OF DEOXYFRENOLICIN AND FRENOLICIN Β (PART II). Heterocyclic Communications. 4(4). 345–350. 2 indexed citations
18.
Armer, Richard, et al.. (1993). Stereoselective synthesis using a thiane oxide system as a disposable template. Journal of the Chemical Society Perkin Transactions 1. 3105–3105. 5 indexed citations
19.
Armer, Richard, et al.. (1993). Application of homochiral lithium amide base chemistry to a thiane oxide system. Journal of the Chemical Society Perkin Transactions 1. 3099–3099. 8 indexed citations
20.
Armer, Richard & Nigel S. Simpkins. (1993). A diastereoselective route to functionalised epoxides by reduction of cyclic β-ketosulphoxides. Tetrahedron Letters. 34(2). 363–366. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026